Magnesium is an essential mineral necessary for optimal cellular health and well-being. Many adults in the United States fail to get recommended amounts of magnesium from their diets. Even so, symptoms of magnesium deficiency are rarely seen; however, maintaining normal body stores could be preventative against common diseases.
MalarkeyLMMcMorrowME. Saunders Nursing Guide to Laboratory and Diagnostic Tests. St Louis, MO: Elsevier Saunders; 2005.
3.
MaierJA. Low magnesium and atherosclerosis: an evidence-based link. Mol Aspects Med. 2003;24:137–146.
4.
McCanceKLHuetherSE. Pathophysiology: The Biologic Basis for Disease in Adults and Children.5th ed.Chicago, IL: Mosby; 2006.
5.
Institute of Medicine.Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington, DC: National Academies Press; 1999.
6.
FordESMokdadAH. Dietary magnesium intake in a national sample of U.S. adults. J Nutr. 2003;133:2879–2882.
7.
JaffeR. How to know if you are magnesium deficient: 75 percent of Americans are. http://www.innovativehealing.com. Accessed January 3, 2011.
TrendelenburgF. Physiologische und pharmakologische untersuchungen an der isolierten bronchialmuskulatur. Arch Exp Pharmacol Ther. 1912;19:79–107.
13.
RoselloJCPlaJC. Sulfato de magnesio en la crisis de asma. Prensa Med Argent. 1936;23:1677–1680.
14.
BicharaMDGoldmanRD. Magnesium for treatment of asthma in children. Can Fam Physician. 2009;55:887–889.
15.
Gontijo-AmaralCRibeiroMAGontijoLSCondino-NetoARibeiroJD. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial. Eur J Clin Nutr. 2007;61:54–60.
16.
BedeONagyDSurányiAHorvathISzlávikMGyurkovitsK. Effects of magnesium supplementation on the glutathione redox system in atopic asthmatic children. Inflamm Res. 2008;57:279–286.
17.
BedeOSurányiAPintérKSzlávikMGyurkovitsK. Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: a randomized, placebo-controlled, double-blind study. Magnes Res. 2003;16:262–270.
18.
BrittonJPavordIRichardsK. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult. Lancet. 1994;344:357–362.
19.
FogartyALewisSAScrivenerSL. Oral magnesium and vitamin C supplements in asthma: a parallel group randomized placebo-controlled trial. Clin Exp Allergy. 2003;33:1355–1359.
20.
FogartyALewisSAScrivenerSL. Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomised trial. Respir Med. 2006;100:174–179.
21.
HijaziNAbalkhailBSeatonA. Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia. Thorax. 2000;55:775–779.
22.
HillJMicklewrightALewisSBrittonJ. Investigation of the effect of short-term change in dietary magnesium intake in asthma. Eur Respir J. 1997;10:2225–2229.
23.
KazaksAGUriu-AdamsJAlbertsonTEShenoySFSternJS. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. J Asthma. 2010;47:83–92.
24.
BlitzMBlitzSBeaselyR. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev. 2005;(4):CD003898. doi:10.1002/14651858.CD003898.pub4.
25.
CheukDChauTLeeSL. A meta-analysis on intravenous magnesium sulphate for treating acute asthma. Arch Dis Child. 2005;90:74–77.
26.
RoweBHBretzlaffJBourdonCBotaGBlitzSCamargoCA. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev. 2000;(1):CD001490. doi:10.1002/14651858.CD001490.
27.
BergaJStovnerLJ. Cost of migraine and other headaches in Europe. Eur J Neurol. 2005;12(Suppl 1):59–62.
MauskopAAlturaBM. Magnesium for migraine: rationale for use and therapeutic potential. CNS Drugs. 1998;9:185–190.
30.
MazzottaGSarchielliPAlbertiAGallaiV. Intracellular Mg++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia. 1999;19:802–809.
31.
TurlapatyPDAlturaBM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science. 1980;208:198–200.
32.
CadyRKFarmerKUAlturaBTAlturaBMCarmichaelC. The effect of magnesium on the responsiveness of migraineurs to a 5-HT1 agonist. Neurology. 1998;50(Suppl 4):A340.
33.
MauskopAAlturaBTCraccoRQAlturaBM. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci. 1995;89:633–636.
34.
BigalMEBordiniCATepperSJSpecialiJG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22:345–353.
35.
DemirkayaSVuralODoraBTopçuoğluMA. Efficacy of intravenous magnesium sulphate in the treatment of acute migraine attacks. Headache. 2001;41:171–177.
36.
MauskopAAlturaBTCraccoRQAlturaBM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache. 1996;36:154–160.
37.
CeteYDoraBErtanCOzdemirCOktayC. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the emergency department. Cephalalgia. 2005;25:199–204.
38.
CorboJEssesDBijurPElannacconeRGallagherEJ. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for the emergency department of migraine headache. Ann Emerg Med. 2001;38:621–627.
39.
ThomasJTombEThomasEFaureG. Migraine treatment by oral magnesium intake and correction of the irritation of buccofacial and cervical muscles as a side effect of mandibular imbalance. Magnes Res. 1994;7:123–127.
40.
GokselBKTorunDKaracaS. Is low blood magnesium level associated with hemodialysis headache?. Headache. 2006;46:40–45.
41.
CastelliSMeossiCDomeniciRFontanaFStefaniG. Magnesium in the prophylaxis of primary headache and other periodic disorders in children. Pediatr Med Chir. 1993;15:481–488.
42.
GrazziLAndrasikFUsaiSBussoneG. Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. Neurol Sci. 2007;28:148–150.
43.
GrazziLAndrasikFUsaiSBussoneG. Magnesium as a treatment for paediatric tension-type headache: a clinical replication series. Neurol Sci. 2005;25:338–341.
44.
WangFVanDEAckersonLMSalkSEReinceRHElinRJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache. 2003;43:601–610.
45.
FacchinettiFSancesGBorellaPGenazzaniARNappiG. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31:298–301.
46.
KöseogluETalasliogluAGönülASKulaM. The effects of magnesium prophylaxis in migraine without aura. Magnes Res. 2008;21:101–108.
47.
PeikertAWilimzigCKöhne-VollandR. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16:257–263.
48.
PfaffenrathVWesselyPMeyerC. Magnesium in the prophylaxis of migraine-a double-blind, placebo-controlled study. Cephalalgia. 1996;16:436–440.
49.
EvansRWTaylorFR. “Natural” or alternative medications for migraine prevention. Headache. 2006;46:1012–1018.
50.
MauskopA. Evidence linking magnesium deficiency to migraines. Cephalalgia. 1999;19:766–767.
HagaH. Effects of dietary magnesium supplementation on diurnal variations of blood pressure and plasma Na+, K(+)-ATPase activity in essential hypertension. Jpn Heart J. 1992;33:785–800.
54.
AlturaBMAlturaBT. Magnesium electrolyte transport and coronary vascular tone. Drugs. 1984;28(Suppl 1):120–142.
55.
SanjulianiAFde Abreu FagundesVGFrancischettiEA. Effects of magnesium on blood pressure and intracellular ion levels of Brazilian hypertensive patients. Int J Cardiol. 1996;56:177–183.
56.
RosanoffA. Magnesium supplements may enhance the effect of antihypertensive medications in stage 1 hypertensive subjects. Magnes Res. 2010;23:27–40.
57.
HatzistavriLSSarafidisPAGeorgianosPI. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens. 2009;22:1070–1075.
58.
BellMJ. A historical overview of pre-eclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs. 2010;39:510–518.
59.
McCoySBaldwinK. Pharmacotherapeutic options for the treatment of pre-eclampsia. Am J Health Syst Pharm. 2009;66:337–344.
GreeneMF. Magnesium sulfate for pre-eclampsia. N Engl J Med. 2003;348:275–276.
62.
Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomized trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG. 2007;114:300–309.
63.
Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomized trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG. 2007;114:289–299.
64.
GabyAR. Nutritional treatments for acute myocardial infarction. Altern Med Rev. 2010;15:113–123.
65.
BaroldiG. Acute coronary occlusion as a cause of myocardial infarct and sudden coronary heart death. Am J Cardiol. 1965;16:859–880.
66.
SinghRB. Effect of dietary magnesium supplementation in the prevention of coronary heart disease and sudden cardiac death. Magnes Trace Elem. 1990;9:143–151.
67.
MathersTWBeckstrandRL. Oral magnesium supplementation in adults with coronary heart disease or coronary heart disease risk. J Am Acad Nurse Pract. 2009;21:651–657.
68.
AbbottRDAndoFMasakiKH. Dietary magnesium intake and the future risk of coronary artery disease (The Honolulu Heart Program). Am J Cardiol. 2003;92:665–669.
69.
FuentesJCSalmonAASilverMA. Acute and chronic oral magnesium supplementation: effects on endothelial function, exercise capacity, and quality of life in patients with symptomatic heart failure. Congest Heart Fail. 2006;12:9–13.
PokanRHofmannPvon DuvillardSP. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med. 2006;40:773–778.
72.
TouyzRM. Magnesium in clinical medicine. Front Biosci. 2004;9:1278–1293.
73.
Al-DelaimyWLRimmEBWillettWCStampferMJHuFB. Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr. 2004;23:63–70.
74.
SongYMansonJECookNRAlbertCMBuringJELiuS. Dietary magnesium intake and risk of cardiovascular disease among women. Am J Cardiol. 2005;96:1135–1141.
75.
UeshimaK. Magnesium and ischemic heart disease: a review of epidemiological, experimental, and clinical evidences. Magnes Res. 2005;18:275–284.
76.
MartiniLCataniaASFerreiraSRG. Role of vitamins and minerals in prevention and management of type 2 diabetes mellitus. Nutr Rev. 2010;68:341–354.
77.
TakayaJHigashinoHKobayashiY. Intracellular magnesium and insulin resistance. Magnes Res. 2004;17:126–136.
78.
De LeeuwIEngelenWDe BlockCVan GaalL. Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm). Magnes Res. 2004;17:109–114.
79.
de ValkHWVerkaaikRvan RijnHJGeerdinkRAStruyvenbergA. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med. 1998;15:503–507.
80.
HuertaMGRoemmichJNKingtonML. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28:1175–1181.
81.
LarssonSCWolkA. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 2007;262:208–214.
82.
HadjistavriLSSarafidisPAGeorgianosPI. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid level profile. Med Sci Monit. 2010;16:PI13–PI18.
83.
JohansonJF. Review of the treatment options for chronic constipation. MedGenMed. 2007;9:25.
84.
LemboACamilleriM. Chronic constipation. N Engl J Med. 2003;349:1360–1368.
MurakamiKSasakiSOkuboHTakahasiYHosoiYItabashiM;Freshman in Dietetic Courses Study II Group. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr. 2007;61:616–622.
